CRH plc (CRH) is down 4.7% today. Here is some analysis on what might have caused this price movement.
Analysis: The drop appears to be driven mainly by a risk-off session that hit materials and industrial shares, with an added (but comparatively small) technical impact from CRH trading ex-dividend. With the declared dividend at $0.39 per share, the ex-dividend effect alone would not typically explain a move of this size, suggesting macro/sector pressure did most of the work.
Details:
Sources:
CRH, DTCC, Saxo, Finviz
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$CRH Hedge Fund Activity
We have seen 550 institutional investors add shares of $CRH stock to their portfolio, and 448 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- VANGUARD GROUP INC added 14,623,673 shares (+22.7%) to their portfolio in Q4 2025, for an estimated $1,825,034,390
- BLACKROCK, INC. added 11,935,274 shares (+30.6%) to their portfolio in Q4 2025, for an estimated $1,489,522,195
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 11,822,517 shares (-73.8%) from their portfolio in Q4 2025, for an estimated $1,475,450,121
- STATE STREET CORP added 11,167,189 shares (+81.3%) to their portfolio in Q4 2025, for an estimated $1,393,665,187
- GEODE CAPITAL MANAGEMENT, LLC added 5,916,930 shares (+67.3%) to their portfolio in Q4 2025, for an estimated $738,432,864
- JANE STREET GROUP, LLC removed 3,077,908 shares (-95.3%) from their portfolio in Q4 2025, for an estimated $384,122,918
- QUBE RESEARCH & TECHNOLOGIES LTD removed 3,011,163 shares (-90.3%) from their portfolio in Q4 2025, for an estimated $375,793,142
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$CRH Congressional Stock Trading
Members of Congress have traded $CRH stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $CRH stock by members of Congress over the last 6 months:
- REPRESENTATIVE VAL T. HOYLE sold up to $15,000 on 09/23.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
$CRH Analyst Ratings
Wall Street analysts have issued reports on $CRH in the last several months. We have seen 8 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 01/08/2026
- Citigroup issued a "Buy" rating on 01/08/2026
- Wells Fargo issued a "Overweight" rating on 11/07/2025
- RBC Capital issued a "Outperform" rating on 11/07/2025
- Barclays issued a "Overweight" rating on 10/20/2025
- Truist Securities issued a "Buy" rating on 10/02/2025
- B of A Securities issued a "Buy" rating on 09/26/2025
To track analyst ratings and price targets for $CRH, check out Quiver Quantitative's $CRH forecast page.
$CRH Price Targets
Multiple analysts have issued price targets for $CRH recently. We have seen 13 analysts offer price targets for $CRH in the last 6 months, with a median target of $140.0.
Here are some recent targets:
- Adrian Huerta from JP Morgan set a target price of $140.0 on 03/03/2026
- Cedar Ekblom from Morgan Stanley set a target price of $141.0 on 03/02/2026
- Timna Tanners from Wells Fargo set a target price of $135.0 on 02/20/2026
- Anthony Pettinari from Citigroup set a target price of $155.0 on 01/08/2026
- Marcus Cole from UBS set a target price of $147.0 on 01/08/2026
- David Macgregor from Longbow Research set a target price of $160.0 on 12/16/2025
- Brent Thielman from DA Davidson set a target price of $116.0 on 11/12/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.